PATENTS OFFICE JOURNAL - Irish Patents Office

More documents

Recommendations

Info

2641 (14/01/2004) Patents Office Journal (No. 1985) 2001011 SYNGENTA LIMITED, Fernhurst, Haslemere, Surrey GU27 3JE, United Kingdom 04/12/2003 Patent No: 60730; Fungicides Product: Picoxystrobin Market Authorisation: Ireland AP01251, 22/05/2001 Germany 04658-00, 25/04/2001 Certificate Expires on: 17/01/2013 2001013 LIGAND PHARMACEUTICALS, INC., 10275 Science Center Drive, San Diego California 92121-1117, United States of America 05/12/2003 Patent No: 0637297; Compounds having selectivity for retinoid X receptors Product: The active principle BEXAROTENE {4-[1-(3,5,5,8,8-pentamethyl- 5,6,7,8-tetrahydro-2-naphthalenyl)vinyl]benzoic acid} of the medicinal product TARGRETIN in all forms subject to the protection of the basic patent. Market Authorisation: Ireland EU/1/01/178/001, 29/03/2001 European Union EU/1/01/178/001, 29/03/2001 Certificate Expires on: 28/03/2016 2001018 DR. KARL THOMAE GmbH, D-88397, Biberach an der Riss, Germany 04/12/2003 Patent No: 60862; Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid of the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation Product: A pharmaceutical combination containing 200 mg dipyridamole or the physiologically acceptable salts thereof and 25mg acetylsalicyclic acid or the physiologically acceptable salts thereof. Market Authorisation: Ireland PA 7/13/2, 09/03/2001 France 343 234-9, 09/07/1997 Certificate Expires on: 08/07/2012 2001019 ORTHO PHARMACEUTICAL CORPORATION, U.S. Route #202, P.O. Box 300, Raritan, New Jersey 08869-0606, United States of America 04/12/2003 Patent No: 63856; Pharmaceutically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same Product: Tepoxalin or a pharmaceutically acceptable salt thereof Market Authorisation: Ireland EU/2/00/028/001-008, 13/03/2001 European Union EU/2/00/028/001-008, 13/03/2001 Certificate Expires on: 27/05/2012
(No. 1985) Patents Office Journal (14/01/2004) 2642 2001027 PENTECH PHARMACEUTICALS, INC., 417 Harvester Court, Wheeling, IL 60090, United States of America QUEEN'S UNIVERSITY AT KINGSTON, 76 Stuart Street, Kingston Ontario K7L 2V7, Canada 04/12/2003 Patent No: 0758895; Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction Product: Apomorphine or a pharmaceutically-acceptable acid addition salt thereof, especially the hydrochloride Market Authorisation: Ireland EU/1/01/180/001-010, 28/05/2001 European Union EU/1/01/180/001-010, 28/05/2001 Certificate Expires on: 27/05/2016 2001028 KIRIN-AMGEN, INC., 6002 Lucerne (CH), Switzerland 04/12/2003 Patent No: 0640619; Erythropoietin analogs with additional glycosylation sites Product: Darbepoetin alfa Market Authorisation: Ireland EU/1/01/185/001-030, 08/06/2001 European Union EU/1/01/185/001-030, 08/06/2001 Certificate Expires on: 07/06/2016 2001029 MERCK & CO., INC., Rahway, New Jersey 07065-9000, United States of America 04/12/2003 Patent No: 0620232; Aza cyclohexapeptide compounds Product: Caspofungin, optionally in the form of pharmaceutically acceptable salt, especially caspofungin acetate. Market Authorisation: Ireland EU/1/01/196/001-003, 24/10/2001 European Union EU/1/01/196/001-003, 24/10/2001 Certificate Expires on: 23/10/2016 2001030 AVENTIS PHARMA S.A., 102 route de Noisy, F-93235 Romainville Cedex, France 04/12/2003 Patent No: 0680967; Erythromycin derivatives, their process of preparation and their use as medicaments Product: Telithromycin and its pharmaceutically acceptable acid addition salts. Market Authorisation: Ireland EU/1/01/191/001 - 004, 09/07/2001 European Union EU/1/01/191/001-004, 09/07/2001 Certificate Expires on: 08/07/2016
Page 1 and 2:
PATENTS OFFICE JOURNAL IRISLEABHAR
Page 3 and 4:
(No. 1985) Patents Office Journal (
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124: (No. 1985) Patents Office Journal (
Page 173: (No. 1985) Patents Office Journal (
Page 185 and 186: (14/01/2004) Patents Office Journal
Page 225 and 226:
(14/01/2004) Patents Office Journal
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315:
show all

PATENTS OFFICE JOURNAL - Irish Patents Office

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?